SecBot SecBot
SC 13G ·Filed Nov 10, 2026

RIGL

RIGEL PHARMACEUTICALS INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed6d 17h ago SEC0000093751-26-000717
Passive investor 5%+ stake
Actionable Insight • Neutral

This is a routine passive disclosure by a large index/asset manager. No change in investment thesis. Monitor future 13F filings for position size changes and any 13D conversion by other holders.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$43.91
T+0 close · Nov 10, 2026 · via day close
Latest settled
+1.39%
T+1 · $44.52
Vs SPY
+0.07%
α at T+1
Next horizon
T+5
in 4h
  1. T+0 · Nov 10 $43.91entry
  2. T+1 · 6d ago +1.39%α +0.07% · $44.52
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corporation filed a Schedule 13G disclosing a 4.7% passive stake in Rigel Pharmaceuticals as of September 30, 2026. The filing confirms State Street's position as a top institutional holder, consistent with its prior 13F holdings, and carries no activist intent.

Key Financial Metrics

Stake
4.7%
Investor
STATE STREET CORP
Investor Type
index fund

Key Facts

  • State Street Corp disclosed beneficial ownership of 879,862 shares of Rigel Pharmaceuticals common stock.
  • The stake represents 4.7% of shares outstanding as of September 30, 2026.
  • The filing is a new Schedule 13G (not an amendment) under Rule 13d-1(b), certifying passive intent.
  • State Street is a large custodian bank and index fund manager; its 13F as of Q2 2026 showed a $41M position in RIGL.
  • The filing was made five days after Rigel reported Q3 2026 earnings (revenue $80.9M, GAAP EPS $0.65).

Financial Impact

4.7% of shares outstanding, valued at approximately $35M based on $747M market cap

ownership

Risk Factors

  • No activist or control intent is signaled; the filing is purely informational.
  • State Street's stake is below the 5% threshold that would trigger a 13G filing; the filing appears to be a voluntary disclosure or a correction.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
73% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000717
Document: 0000093751-26-000717-index.html0000093751-26-000717
Document: 0000093751-26-000717.txt0000093751-26-000717

Track record

12 reports on RIGL

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.02% at T+60 after the May 12, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $45.03 Now $43.73 −2.89% settles Feb 12
  2. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $44.21 Now $43.73 −1.09% settles Feb 12
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $43.91 Now $43.73 −0.41% settles Feb 8
  4. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $39.65 Now $43.73 −10.29% settles Feb 4
  5. Aug 4, 202614w ago 8-K Mixed 6/10 Entry $40.48 to $50.92 Now $43.73 +8.03% ▲ +25.79% +25.60% vs SPY
  6. Jun 17, 202621w ago 8-K Neutral 4/10 Entry $32.91 to $45.35 Now $43.73 +32.88% ▲ +37.80% +35.91% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $32.08 to $48.67 Now $43.73 +36.32% ▲ +51.71% +47.32% vs SPY
  8. May 20, 202625w ago 8-K Neutral 2/10 Entry $29.19 to $42.45 Now $43.73 +49.81% ▲ +45.43% +41.13% vs SPY
  9. May 12, 202626w ago 8-K Bullish 7/10 Entry $32.13 to $40.17 Now $43.73 +36.10% ▲ +25.02% +20.59% vs SPY
  10. May 5, 202627w ago 8-K Bearish 7/10 Entry $26.67 to $36.81 Now $43.73 −63.97% ▼ −38.02% −35.96% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026